The total return over the past 12 months is -8.69% vs. +16.94% for the S&P 500. So far it's up -13.23% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (8.69%) | +33.52% | N/A | N/A | N/A | N/A |
| Total Return CAGR | (8.69%) | +33.52% | N/A | N/A | N/A | N/A |
| Revenue CAGR | +20.89% | (5.60%) | +6.75% | +16.66% | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Journey Medical Corporation (DERM)
| Year | Start price | End price | DERM Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $7.71 | $6.69 | (13.23%) | +14.51% | (27.74%) |
| 2025 | $3.91 | $7.71 | +97.19% | +17.72% | +79.47% |
| 2024 | $5.76 | $3.91 | (32.12%) | +24.89% | (57.01%) |
| 2023 | $1.92 | $5.76 | +200.00% | +26.19% | +173.81% |
| 2022 | $5.38 | $1.92 | (64.31%) | (18.17%) | (46.14%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
